Flagship Ventures Fund V, L.P.
Related Filers (28)
- AFEYAN NOUBAR (22)
- Flagship Ventures Fund V General Partner LLC (22)
- Flagship V VentureLabs Rx Fund, L.P. (14)
- Flagship Pioneering Inc. (13)
- Sana Biotechnology, Inc. (10)
- Flagship VentureLabs V LLC (10)
- Flagship Ventures Opportunities Fund I, L.P. (9)
- Flagship VentureLabs V Manager LLC (8)
- Evelo Biosciences, Inc. (7)
- Flagship Ventures Opportunities Fund I General Partner LLC (7)
- Denali Therapeutics Inc. (5)
- Codiak BioSciences, Inc. (5)
- Kaleido Biosciences, Inc. (5)
- Flagship Pioneering Special Opportunities Fund II General Partner LLC (5)
- Flagship Pioneering Special Opportunities Fund II, L.P. (5)
- Sigilon Therapeutics, Inc. (5)
- KANIA EDWIN M JR (4)
- Nutritional Health Side Fund, L.P. (4)
- Nutritional Health Disruptive Innovation Fund, L.P. (4)
- Omega Therapeutics, Inc. (4)
- Rubius Therapeutics, Inc. (3)
- Foghorn Therapeutics Inc. (3)
- Flagship Ventures Fund IV, L.P. (3)
- Flagship Ventures Fund IV General Partner LLC (3)
- Flagship Pioneering Fund VI General Partner LLC (3)
- Flagship Pioneering Fund VI, L.P. (3)
- Flagship VentureLabs IV, LLC (2)
- Flagship Ventures Fund IV-Rx, L.P. (2)
- Show More ...
Other (4)
144
Wednesday, 6/7/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 5/24/2023
Filing for proposed sale of securities under Rule 144
144/A
Wednesday, 5/24/2023
Filing for proposed sale of securities under Rule 144
D
Wednesday, 12/17/2014
Exempt (Private) Offering
Ownership (44)
SC 13G/A
Wednesday, 2/14/2024
Sana Biotechnology, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Sigilon Therapeutics, Inc.: Major Shareholders
4
Friday, 9/15/2023
Sana Biotechnology, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/15/2023
Sigilon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Thursday, 7/13/2023
Evelo Biosciences, Inc.: Major Shareholders
4
Thursday, 6/8/2023
Sana Biotechnology, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/26/2023
Sana Biotechnology, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Monday, 2/27/2023
Omega Therapeutics, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Codiak BioSciences, Inc.: Major Shareholders
4
Friday, 9/16/2022
Codiak BioSciences, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 6/1/2022
Evelo Biosciences, Inc.: Major Shareholders
SC 13G
Monday, 2/14/2022
Sana Biotechnology, Inc.: Major Shareholders
SC 13D
Friday, 8/6/2021
Omega Therapeutics, Inc.: Major Shareholders
4
Thursday, 8/5/2021
Omega Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/29/2021
Omega Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 3/23/2021
Rubius Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 2/16/2021
Denali Therapeutics Inc.: Major Shareholders
SC 13G
Tuesday, 2/16/2021
Codiak BioSciences, Inc.: Major Shareholders
SC 13G
Tuesday, 2/16/2021
Sigilon Therapeutics, Inc.: Major Shareholders
4
Wednesday, 2/10/2021
Sana Biotechnology, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 2/10/2021
Kaleido Biosciences, Inc.: Major Shareholders
SC 13D/A
Thursday, 2/4/2021
Evelo Biosciences, Inc.: Major Shareholders
3
Wednesday, 2/3/2021
Sana Biotechnology, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 12/10/2020
Sigilon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 12/3/2020
Sigilon Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 10/29/2020
Foghorn Therapeutics Inc.: Statement of changes in beneficial ownership of securities
SC 13D
Thursday, 10/29/2020
Foghorn Therapeutics Inc.: Major Shareholders
3
Thursday, 10/22/2020
Foghorn Therapeutics Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 10/20/2020
Codiak BioSciences, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 10/13/2020
Codiak BioSciences, Inc.: Initial statement of beneficial ownership of securities
SC 13D/A
Wednesday, 7/1/2020
Evelo Biosciences, Inc.: Major Shareholders
SC 13D/A
Monday, 6/8/2020
Kaleido Biosciences, Inc.: Major Shareholders
SC 13G/A
Thursday, 2/13/2020
Denali Therapeutics Inc.: Major Shareholders
4
Wednesday, 3/6/2019
Kaleido Biosciences, Inc.: Statement of changes in beneficial ownership of securities
SC 13D
Wednesday, 3/6/2019
Kaleido Biosciences, Inc.: Major Shareholders
3
Wednesday, 2/27/2019
Kaleido Biosciences, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 7/23/2018
Rubius Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 7/17/2018
Rubius Therapeutics, Inc.: Initial statement of beneficial ownership of securities
SC 13D
Monday, 5/21/2018
Evelo Biosciences, Inc.: Major Shareholders
4
Tuesday, 5/15/2018
Evelo Biosciences, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 5/8/2018
Evelo Biosciences, Inc.: Initial statement of beneficial ownership of securities
SC 13G
Wednesday, 2/14/2018
Denali Therapeutics Inc.: Major Shareholders
4
Tuesday, 12/12/2017
Denali Therapeutics Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 12/7/2017
Denali Therapeutics Inc.: Initial statement of beneficial ownership of securities